Chemical Biology Based on Small Molecule-Protein Interaction

Protein Targeting with Small Molecules: Chemical Biology Techniques and Applications

Volumn , Issue , 2009, Pages 1-10

  Osada, Hiroyuki ^a  

^a RIKEN   (Japan)

Author keywords

Bioactive small molecule (SM) profiling for target speculation; Chemical biology and small molecule protein interaction; Chemical biology in biology and drug discovery

Indexed keywords

EID: 84859147365     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470495018.ch1     Document Type: Chapter

References (26)

1. Osada, H. (1998). Bioprobes for investigating mammalian cell cycle control. J. Antibiot., 51, 973-981.
2. Osada, H. (2000). Trends in bioprobe research. In Bioprobes, H. Osada, ed. Springer- Verlag, Tokyo, pp. 1-14.
3. Schreiber, S. L. (1991). Chemistry and biology of immunophilins and their immunosuppressive ligands. Science, 251, 283-287.
4. Schreiber, S. L., Crabtree, G. R. (1992). The mechanism of action of cyclosporin A and FK506. Immunol. Today, 13, 136-142.
5. Cliptone, N. A., Crabtree, R. C. (1992). Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature, 357, 695-697.
6. Schreiber, S. L., Liu, J., Albers, M. W., et al. (1992). Molecular recognition of immunophilins and immunophilin-ligand complexes. Tetrahedron, 48, 2545-2558.
7. Dedera, D., Hu, W., Vander Heyden, N., et al. (1989). Viral protein R of human immunodeficiency virus types 1 and 2 is dispensable for replication and cytopathogenicity in lymphoid cells. J. Virol., 63, 3205-3208.
8. Cohen, E. A., Dehni, G., Sodroski, J. G., et al. (1990). Human immunodeficiency virus Vpr product is a virion-associated regulatory protein. J. Virol., 64, 3097-3099.
9. Watanabe, N., Nishihara, Y., Yamaguchi, T., et al. (2006). Fumagillin suppresses HIV-1 infection of macrophages through the inhibition of Vpr activity. FEBS Lett., 580, 2598-2602.
10. Ingber, D., Fujita, T., Kishimoto, S., et al. (1990). Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature, 348.
11. Teitelbaum, S. L. (2000). Bone resorption by osteoclasts. Science, 289, 1504-1508.
12. Osada, H. (2000). Differentiation. In Bioprobes, H. Osada, ed. Springer-Verlag, Tokyo, pp. 43-65.
13. Kawatani, M., Okumura, H., Honda, K., et al. (2008). The identification of an inhibition through the osteoclastogenesis via inhibition of glyoxalase I. Proc. Natl. Acad. Sci. USA, 105, 11691-11696.
14. Hovius, R., Schmid, E. L., Tairi, A. P., et al. (1999). Fluorescence techniques for fundamental and applied studies of membrane protein receptors: the 5-HT3 serotonin receptor. J. Recept. Signal Transduct. Res., 19, 533-545.
15. Simizu, S., Osada, H. (2000). Mutations in the Plk gene lead to instability of Plk protein in human tumor cell lines. Nat. Cell Biol., 2, 852-854.
16. Watanabe, N., Sekine, T., Takagi, M., et al. (2009). Deficiency in chromosome congression by the inhibition of Plk1 polo box domain-dependent recognition. J. Biol. Chem., 284, 2344-2353.
17. Inamori, Y., Muro, C., Sajima, E., et al. (1997). Biological activity of purpurogallin. Biosci. Biotechnol. Biochem., 61, 890-892.
18. Kitada, S., Leone, M., Sareth, S., et al. (2003). Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins. J. Med. Chem., 46, 4259-4264.
19. Stoughton, R. B., Friend, S. H. (2005). How molecular profiling could revolutionize drug discovery. Nat. Rev. Drug Discov., 4, 345-350.
20. Terstappen, G. C., Schlupen, C., Raggiaschi, R., et al. (2007). Target deconvolution strategies in drug discovery. Nat. Rev. Drug Discov., 6, 891-903.
21. Yaguchi, S., Fukui, Y., Koshimizu, I., et al. (2006). Antitumor activity of ZSTK474, a new phosphatidylinositol 3-kinase inhibitor. J. Natl. Cancer Inst., 98, 545-556.
22. Kanoh, N., Nakamura, T., Honda, K., et al. (2008). Distribution of photo-cross-linked products from 3-aryl-3-trifluoromethyldiazirines and alcohols. Tetrahedron, 64, 5692-5698.
23. Saito, A., Kawai, K., Takayama, H., et al. (2008). Improvement of photoaffinity SPR imaging platform and determination of binding site of p62/SQSTM1 to p38 MAP kinase. Chem. Asian J., 3, 1607-1612.
24. Katagiri, M., Hayashi, M., Matsuzaki, K., et al. (1995). The neuritogenesis inducer lactacystin arrests cell cycle at both G0/G1 and G2 phases in neuro 2a cells. J Antibiot., 48, 344-346.
25. Fenteany, G., Standaert, R. F., Lane, W. S., et al. (1995). Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science, 268, 726-731.
26. Adams, J., (2004). The proteasome: a suitable antineoplastic target. Nat. Rev. Cancer, 4, 349-360.